US Stock MarketDetailed Quotes
PCSA Processa Pharmaceuticals
- 1.9700
- -0.0500-2.48%
Trading May 16 13:54 ET
5.63MMarket Cap-325P/E (TTM)
2.0300High1.9600Low20.30KVolume1.9900Open2.0200Pre Close40.13KTurnover0.81%Turnover RatioLossP/E (Static)2.86MShares18.000052wk High0.63P/B4.92MFloat Cap1.400052wk Low--Dividend TTM2.50MShs Float284.7980Historical High--Div YieldTTM3.47%Amplitude1.4000Historical Low1.9770Avg Price1Lot Size
About Processa Pharmaceuticals Company
Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on March 29, 2011 and is headquartered in Hanover, MD.
Company Profile
SymbolPCSA
Company NameProcessa Pharmaceuticals
Listing DateOct 2, 2020
Issue Price4.00
Founded2011
CEOMr. George K. Ng
MarketNASDAQ
Employees13
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address7380 Coca Cola Drive,Suite 106
CityHanover
ProvinceMaryland
CountryUnited States of America
Zip Code21076
Phone1-443-776-3133
Company Executives
- Name
- Position
- Salary
- George K. Ng
- Chief Executive Officer and Director
- 472.85K
- James H. Stanker
- Chief Financial Officer and Principal Accounting Officer
- 342.62K
- Wendy Guy
- Chief Administrative Officer
- --
- Patrick Lin
- Chief Business and Strategy Officer
- --
- Dr. Sian E. Bigora, Pharm.D.
- Chief Development Officer
- 321.73K
- Justin W. Yorke
- Chairman of the Board
- 54.00K
- Dr. David Young, PhD,Pharm.D.
- Director and President, Research and Development
- 186.64K
- James R. Neal, M.B.A.,M.S.
- Independent Director
- 83.00K
- Khoso Baluch
- Independent Director
- 83.00K
- Geraldine Pannu
- Independent Director
- 54.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg